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cerebral vascular basement membranes form the pathways 
by which fluid passes into and out of the brain but that dif-
ferent basement membrane layers are involved. The signifi-
cance of these findings for neuroimmunology, Alzheimer’s 
disease, drug delivery to the brain and the concept of the 
Virchow–Robin space are discussed.
Keywords Lymphatic drainage · Basement membranes · 
Capillaries · Arteries · Amyloid-β · Nanoparticles 
neuroimmunology · Alzheimer’s disease · Virchow–Robin 
space · Drug delivery
Introduction
There are two major extracellular, extravascular fluids asso-
ciated with the brain, namely CSF in the ventricles and 
subarachnoid spaces and interstitial fluid (ISF) between 
cells within the CNS parenchyma. In most organs of the 
body, interstitial fluid, metabolites and antigen present-
ing cells drain to regional lymph nodes along well-defined 
lymphatic vessels. There are, however, no conventional 
lymphatic vessels in the CNS, but there are lymphatic 
drainage pathways by which CSF and ISF drain to regional 
lymph nodes.
CSF is produced mainly by the choroid plexuses and 
circulates through the cerebral ventricles and the subarach-
noid spaces. Lymphatic drainage of CSF occurs through 
well-defined channels that traverse the cribriform plate of 
the ethmoid bone and carry fluid and tracers from the suba-
rachnoid space to lymphatics in the nasal mucosa and to 
cervical lymph nodes [5]. In addition, there is lymphatic 
drainage of CSF along cranial and spinal nerve roots and 
into lymphatics in the dura mater [17]. In larger mammals, 
including humans, CSF also drains directly into the blood 
Abstract In the absence of conventional lymphatics, 
drainage of interstitial fluid and solutes from the brain 
parenchyma to cervical lymph nodes is along basement 
membranes in the walls of cerebral capillaries and tunica 
media of arteries. Perivascular pathways are also involved 
in the entry of CSF into the brain by the convective influx/
glymphatic system. The objective of this study is to differ-
entiate the cerebral vascular basement membrane pathways 
by which fluid passes out of the brain from the pathway by 
which CSF enters the brain. Experiment 1: 0.5 µl of soluble 
biotinylated or fluorescent Aβ, or 1 µl 15 nm gold nanopar-
ticles was injected into the mouse hippocampus and their 
distributions determined at 5 min by transmission electron 
microscopy. Aβ was distributed within the extracellular 
spaces of the hippocampus and within basement mem-
branes of capillaries and tunica media of arteries. Nanopar-
ticles did not enter capillary basement membranes from the 
extracellular spaces. Experiment 2: 2 µl of 15 nm nanopar-
ticles were injected into mouse CSF. Within 5min, groups 
of nanoparticles were present in the pial-glial basement 
membrane on the outer aspect of cortical arteries between 
the investing layer of pia mater and the glia limitans. The 
results of this study and previous research suggest that 
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via arachnoid villi and granulations associated with venous 
sinuses.
Whereas there is a direct connection between the CSF 
and lymphatics in the nasal mucosa and dura mater, there 
is no direct link between ISF and conventional lymphatic 
vessels. Instead, lymphatic drainage of ISF occurs along 
basement membranes in the walls of cerebral capillaries 
and arteries at an estimated rate of 0.11–0.29 µl/min/g 
of brain [2, 23]. Although entry of ISF into lymph nodes 
from artery walls probably involves lymphatic vessels 
these have, as yet, not been defined. Evidence for lym-
phatic drainage along walls of cerebral blood vessels is 
derived from experimental studies and from observa-
tions in human cerebral amyloid angiopathy (CAA). 
When small volumes of soluble tracer are injected (0.5 μl 
injected over a period of 2 min) into the ISF of grey mat-
ter of the mouse striatum or hippocampus, tracer initially 
diffuses through the extracellular spaces of the brain but 
within 5 min has entered basement membranes in the 
walls of capillaries and cerebral arteries to drain out of the 
brain. If larger volumes are injected, tracer is not retained 
within the brain parenchyma and may pass into CSF 
in the ventricles [7]. Flow of ISF and tracers out of the 
brain along blood vessel walls is specifically along base-
ment membranes between capillary endothelium and glia 
limitans and along basement membranes that surround 
smooth muscle cells in the tunica media of cerebral arter-
ies in a three-dimensional network. Studies using radioac-
tive human serum albumin have shown that tracers drain 
from the brain to cervical lymph nodes along the walls 
of leptomeningeal arteries and the internal carotid artery 
in the neck [23]. These experiments have also shown that 
only 5–10 % of tracer injected into the striatum leaks into 
the CSF, suggesting that the lymphatic drainage of ISF 
by the pericapillary and periarterial route is largely sepa-
rate from the CSF [23]. One important role of intramu-
ral perivascular drainage along basement membranes lies 
in the transfer of soluble antigens from the CNS paren-
chyma to regional lymph nodes. The basement membrane 
pathways are too narrow to allow passage of antigen pre-
senting cells and lymphocytes from the brain to regional 
lymph nodes and this may be a major factor for the immu-
nological privilege of the brain [7, 8].
Another key role for intramural perivascular drainage 
along basement membranes is the elimination of solutes, 
such as soluble amyloid β (Aβ) from the brain. As arter-
ies age, perivascular lymphatic drainage becomes less effi-
cient and insoluble, fibrillary Aβ among other amyloids is 
deposited in the walls of cerebral capillaries and arteries 
as cerebral amyloid angiopathy (CAA) [24]. The distribu-
tion of Aβ in vascular basement membranes in the early 
stages of CAA in the human brain is exactly the same as 
the distribution of soluble tracers injected into the mouse 
brain, i.e. in capillary basement membranes and in base-
ment membranes in the tunica media of arteries. In effect, 
Aβ produced by the brain acts as a natural tracer for lym-
phatic drainage in the human and mouse brain [13]. Base-
ment membranes of arterial endothelium and basement 
membranes on the outer aspects of arteries are devoid of 
soluble tracer in the experimental animals and of Aβ in 
the early stages of human CAA. Thus, experimental data 
derived from mouse studies on lymphatic drainage of the 
brain are highly relevant for the human brain, CAA and 
Alzheimer’s disease.
The walls of cerebral arteries and capillaries are not only 
routes for the lymphatic drainage of ISF and solutes out of 
the brain, they are also routes by which CSF and tracers 
enter the brain from the subarachnoid space and mix with 
ISF. Injection of horseradish peroxidase [20] and a variety 
of fluorescent tracers into the CSF [15] results in their entry 
into the brain alongside cortical arteries and penetration of 
tracers into basement membranes surrounding capillaries.
This system has been termed convective influx [20] or 
the glymphatic [27] system as entry of tracers from the 
CSF into the ISF of the brain parenchyma involves aqua-
porin 4 in perivascular astrocytes.
The objective of the present study is to define, by trans-
mission electron microscopy, the routes by which tracers 
pass into and out of the brain. We study the fine anatomy 
of the cerebral capillary wall and surrounding brain tissue 
to identify connections between the extracellular spaces 
and capillary basement membranes through which fluid 
and solutes may flow to enter the start of the perivascular 
lymphatic drainage pathway. Intramural perivascular drain-
age is used as the most suitable term and it is recognised 
that lymphatic drainage along the walls of arteries is actu-
ally along basement membranes within the tunica media 
rather than on the outside of the artery. In addition, the 
present study includes a comparison of the capacity of a 
soluble tracer, biotinylated Aβ, to pass from the extracel-
lular spaces of cerebral grey matter into capillary basement 
membranes with the failure of 15 nm gold nanoparticles to 
pass by the same route.
To define the exact route by which tracers enter the brain 
from the CSF, we injected 15 nm gold nanoparticles into 
the CSF and traced their passage into the brain along base-
ment membranes at the outer extremity of the artery wall 
between the coating of pia mater and the glia limitans. This 
entry pathway is distinct from the pathway along basement 
membranes surrounding smooth muscle cells in the tunica 
media by which drainage out of the brain occurs. The pre-
sent study supports the hypothesis that vascular basement 
membranes are major routes for the transport of fluid and 
tracers into and out of the brain parenchyma.
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Materials and methods
Intracerebral injections
All mice were kept on a standard 12-h light/dark cycle and 
allowed food and water ad libitum. All experiments were 
carried out in accordance with animal care guidelines stipu-
lated by the Animal Care and Use Committee at the Univer-
sity of Southampton and the Home Office (PPL 30/3095). 
The anaesthetic used for all mice consisted of a combina-
tion of 10 mg/ml ketamine (Pfizer) with 1 mg/ml xylazine 
(Bayer), injected intraperitoneally 0.1 ml per 10 g body 
weight. The glass capillary micropipette routinely used for 
our intracerebral injections was purchased from Sigma UK 
and the tip was adjusted to a diameter of <50 μm using a 
Sutter P97 Flaming Brown Pipette puller. The exact vol-
umes and concentrations for intracerebral injections are 
described below. Mice were culled at 5 min after with-
drawal of the glass capillary through overdose with pento-
barbital 200 mg/kg. Mice were intracardially perfused with 
0.1 M piperazine-N,N′-bis(2-ethanesulfonic acid) buffer 
(PIPES, PH 7.2) followed by 3.4 % formaldehyde plus 
3 % glutaraldehyde in 0.1 M PIPES buffer. Brains were 
removed through dissection from the skull, post-fixed over-
night in fresh fixative and then sectioned into 200 μm thick 
coronal slices using a vibratome.
Intraparenchymal injections of Aβ
To determine the ultrastructural location of soluble Aβ 
within the ISF as it moves from the parenchyma to the 
blood vessels, 10-week-old male wild-type C57Bl6 mice 
(n = 6) were micro-injected into the hippocampus with 
0.5 μL biotinylated human Aβ40 of 100 μM concentration 
(AnaSpec, USA), using the injection technique described 
before [11]. Biotinylated Aβ was used to prevent any 
potential cross-reactivity between exogenous human Aβ 
and endogenous mouse Aβ. Three mice were injected only 
with phosphate buffered saline, serving as controls. The 
specificity of Aβ staining was confirmed by pre-incubating 
biotinylated Aβ injected tissue sections with avidin, to satu-
rate the biotin binding sites bound the Aβ. Following this, 
the sections underwent 4G8 anti-Aβ immunohistochem-
istry using DAB as a chromagen (n = 3 mice) or immu-
nofluorescence (n = 3) using streptavidin Alexa Fluor 546 
(Invitrogen, UK).
To identify the clearance pathway of Aβ from the brains 
of naïve mice at the ultrastructural level, six free-floating 
sections of 100 μm thickness, from the hippocampus of 
mice injected with biotinylated human Aβ40 and from con-
trol mice injected with phosphate buffered saline were pro-
cessed for enzyme-linked immunohistochemistry. Sections 
were washed 3 × 5 min in PBS before being treated with 
70 % formic acid for 30 s. After washing for 3 × 5 min sec-
tions were treated with 3 % hydrogen peroxide for 30 min. 
The sections were washed a further 3 × 5 min in PBS. Fol-
lowing this, sections were treated for 1 h at room tempera-
ture with Vectastain™ ABC kit and developed using glu-
cose oxidase enhancement with DAB as chromogen. Some 
sections were mounted onto frosted slides, dehydrated 
and coverslipped using DPX mounting medium. These 
sections were imaged using Nikon 80i brightfield micro-
scope at 10× and 175× magnification and images were 
exported to Photoshop CS software, for orientation. Sec-
tions for TEM were transferred into 0.1 M phosphate buffer 
(PB), pH 7.2 for 3 × 5 min washes before being post-fixed 
with 1 % osmium tetroxide in 0.1 M PB, pH 7.2 for 1 h at 
room temperature. After further 3 × 5 min washes in PBS, 
the sections were dehydrated through an alcohol series 
(30 %–2 min, 50 %–2 min, 70 %–10 min, 90 %–10 min, 
2 × 100 %–20 min). Sections were then treated with ace-
tonitrile for 10 min before being left in a 50:50 mixture 
of acetonitrile and TAAB resin (TAAB laboratories, UK) 
for 12 h. Following resin infiltration, sections were placed 
into fresh TAAB resin for 6 h before being embedded in 
fresh TAAB resin and were polymerised at 60 °C for 48 h. 
Polymerised resin blocks were sectioned using a Reichurt 
Ultracut E ultramicrotome (Reichurt, Germany). Semi-thin 
sections (0.5 μm thick) were cut and stained with toluidine 
blue (Agar Scientific, UK). These sections were analysed 
using a Nikon 80i brightfield microscope at 10× and 175× 
magnification to assess the quality of the tissue. Regions 
with good ultrastructural preservation were further micro-
dissected. Ultra-thin sections (90 nm thick) were cut from 
the microdissected block using a diatome diamond knife 
and floated on to TEM grids for visualisation. In total, 
36 sections were analysed by TEM and Aβ was observed 
within 5–10 capillaries per section. Examination through 
the section covered every grid square from top right to bot-
tom left. Analysis was performed using a Hitachi H7000 
transmission electron microscope. Images were captured 
using iTEM software (Universal TEM Imaging Platform, 
Soft Imaging System, Münster, Germany) operating a Meg-
aView III digital camera (Soft Imaging System, Münster, 
Germany).
Immunofluorescence for the localisation of Aβ
For double labelling immunohistochemistry, tissue sec-
tions were incubated overnight with anti-α smooth muscle 
actin (1:500, Sigma-Aldrich, Dorset, UK) and anti-laminin 
(1:500, Sigma-Aldrich, Dorset, UK) and developed with 
Alexa Fluor-conjugated secondary antibodies (Invitrogen, 
Paisley, UK). Photomicrographs of triple labelling immu-
nohistochemistry were captured from tissue sections at 
least 100 μm away from the injection site using a Leica 
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SP5 confocal laser scanning microscope (Milton Keys, 
UK) and exported to Photoshop CS software.
Synthesis of citrate coated spherical gold nanoparticles 
of 15 nm diameter
Sodium citrate stabilized spherical gold nanoparticles 
(NPs) were prepared using the Turkevich method [18]. 
Briefly, 2.5 ml of 19.5 mM trisodium citrate was brought 
to boil and quickly mixed with a boiled solution of sodium 
tetrachloroaurate (III) dehydrate (0.5 mM, 25 ml) whilst 
stirring vigorously (the solution changes colour from pale 
yellow to colourless, then to purple and finally to deep red 
indicating the formation of 15 nm spherical gold NPs). 
After 5 min the solution was cooled to room temperature 
and filtered using a 0.45 μm syringe filter. The citrate 
coated NPs were then capped with bis-(p-sulfonatophenyl) 
phenylphosphine dihydrate dipotassium (BSPP) by mix-
ing 27.5 ml of gold NPs with 10 mg of BSPP and stir-
ring overnight, precipitated using 50 mg of sodium chlo-
ride and purified by centrifugation at 5000 rpm for 5 min 
at 20 °C. The resulting nanoparticles were re-dispersed by 
sonication in 100 μl of Milli-Q water and stored at 4 °C. 
The size of the gold nanoparticles was confirmed by TEM 
using 3.05 mm diameter Carbon coated 400 mesh Copper 
grids and UV–visible spectroscopy. Gold NP concentration 
was estimated using Beer–Lambert law and then diluted in 
Milli-Q water to the desired concentration.
Surface functionalization of 15 nm gold nanoparticles
Citrate coated spherical NPs of 15 nm diameter were 
coated with Polyethylene glycol (PEG) compounds con-
taining either a positive (SH-PEG-COOH), neutral (SH-
PEG-OCH3) or negative (SH-PEG-NH2) function group. 
For each function group, NPs (5 nm, 10 ml) were mixed 
with the PEG compound (5 mg, 200 μl) whilst continually 
stirring, incubated for 2 h on a shaker (500 rpm) and left 
overnight at 4 °C. Functionalised gold NPs were then puri-
fied by centrifugation (3 × 16,400 rpm, 15 min, 10 °C) and 
re-dispersed by sonication in 100 μl of Milli-Q water.
Intraparenchymal injections of 15 nm Gold 
nanoparticles
10-week-old male mice were injected stereotactically 
with 1 μl of either positive, negative or neutrally charged 
15 nm gold nanoparticles (n = 3/group) into the left hip-
pocampus over 5 min, at a rate of 0.2 μl/min (coordi-
nates from Bregma: AP = −1.9 mm; ML = 1.5 mm 
and DV = −1.3 mm). Injection pipettes were left in situ 
for 2 min to prevent reflux and mice were killed 5-min 
postinjection.
Coronal slices at 200, 400, 600 and 800 μm anterior and 
posterior to the hippocampi injection site were prepared for 
examination by TEM. For each 100 μm slice four 1 mm2 
samples were microdissected from the left hippocam-
pus and processed for TEM (32 × samples per mouse, 
96 × samples per group). TEM was performed by methodi-
cally scanning each sample from top right to bottom left 
with areas containing nanoparticles digitally photographed.
Injections of 15 nm gold nanoparticles into Cisterna 
Magna
Anaesthetised 10-week-old male mice (n = 3) were placed 
prone on a stereotaxic instrument and secured with head 
adaptors. A sagittal incision of the skin was made infe-
rior to the occiput, the subcutaneous tissue and biventer 
cervicis and rectus capitis dorsalis major muscles were 
bluntly separated to expose the posterior atlanto-occipital 
membrane that was incised to reveal the dura mater of the 
cisterna magna. The position of the mouse was then read-
justed so that the head formed a 135° angle with the body. 
The exposed dura mater was then pierced with the injec-
tion pipette lateral to the arteria dorsalis spinalis and 2 μl 
of 15 nm negative gold nanoparticles was injected over 
2.5 min, at a rate of 0.8 μl/min. Injection pipettes were 
left in situ for 2 min to prevent reflux and mice were killed 
5 min postinjection. Perfusion-fixation, removal and sec-
tioning of brains were performed as described above. The 
parietal cortex and corpus callosum were microdissected 
and processed for TEM according to methods developed by 
us and described above and in previous studies [22].
Results
Connections between extracellular spaces in grey 
matter of the brain and pericapillary basement 
membranes
Electron microscope preparations were used to examine the 
relationship between the extracellular spaces in the mouse 
hippocampus and basement membranes surrounding capil-
laries. Figure 1a shows the narrow and tortuous extracel-
lular spaces in the brain parenchyma outlined in yellow 
and how they abut on to the walls of capillaries. At higher 
magnification in Fig. 1b, the interface of the extracellular 
space between astrocyte processes and the basement mem-
brane of the capillary wall can be demonstrated. The base-
ment membrane around capillaries is formed from two ele-
ments derived on one side from the astrocytes of the glia 
limitans and on the other side from capillary endothelium; 
it is in direct focal contact with the extracellular space of 
the brain.
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Distribution of biotinylated Aβ injected into the 
hippocampus
From previous experiments using fluorescent tracers [7] it 
was estimated that 5 min after injection would be the opti-
mal time to examine the relationship between biotinylated 
Aβ in the extracellular spaces of the brain and the presence 
of biotinylated Aβ in capillary basement membranes. At 
later times, fluorescent tracer is reduced in amount in the 
extracellular spaces and this is accompanied by reduced 
presence of tracer in capillary basement membranes.
At 5 min after injection into the hippocampus, densely 
staining biotinylated Aβ is seen in the narrow extracellu-
lar spaces between neuronal and glial processes (Fig. 2a). 
Examination of capillary walls at the same time interval 
reveals the presence of dark granular staining for biotinylated 
Aβ within the capillary basement membrane (Fig. 2b). 
At higher magnification (Fig. 2c), staining for Aβ extends 
throughout the width of the basement membrane and on 
either side of a pericapillary pericyte. Images were compared 
with basement membranes from capillaries of animals that 
had received injections of phosphate buffered saline and no 
injection of biotinylated Aβ (Fig. 2d); basement membranes 
in non-injected animals show no granular dense staining for 
Aβ.
Aβ in basement membranes of the tunica media 
of leptomeningeal arteries 5 min after injection 
of fluorescent Aβ into the hippocampus
To demonstrate that soluble Aβ injected into the hippocam-
pus reaches leptomeningeal arteries 5 min after injection, 
sections of brain were examined by immunocytochemistry 
and confocal microscopy. Figure 3 shows a series of confo-
cal images that depict staining for Aβ, basement membrane 
laminin and smooth muscle actin. The leptomeningeal 
artery in Fig. 3 is seen as a cylinder viewed obliquely and 
end-on. Aβ (Fig. 3a) has a similar pattern of staining in the 
vessel wall to laminin (Fig. 3b) but not exactly the same. 
Differences can be detected in the merged image (Fig. 3d); 
although Aβ merges with laminin throughout the length of 
the section of the vessel wall, the tunica adventitia on the 
outer aspect of the artery stains for laminin but is devoid 
of Aβ. Figure 3c shows a thin but complete circumferential 
coat of smooth muscle cells in the artery wall that is most 
strongly visible where the artery is cut in transverse sec-
tion. The completeness of the smooth muscle coat allows 
arteries to be distinguished from veins that have only occa-
sional smooth muscle cells in their walls. Basement mem-
brane staining for laminin and Aβ is associated with the 
smooth muscle cell layer (Fig. 3d). These images support 
previously published data [7] showing fluorescent tracers 
within the basement membranes of the tunica media of cer-
ebral arteries. No tracer was observed in association with 
veins.
Distribution of 15 nm gold nanoparticles in the 
hippocampus 5 min after injection
To test the capacity of the pericapillary route for lym-
phatic drainage, 15 nm gold nanoparticles were injected 
into the grey matter of the hippocampus and specimens 
were examined 5 min after injection. In this way the results 
could be compared with the injections of biotinylated Aβ. 
Fig. 1  Extracellular space in grey matter of the hippocampus and 
its connection to capillary basement membrane. a Grey matter with 
the extracellular space outlined in yellow. There is a capillary in the 
bottom left-hand corner. Capillary lumen (lu). b High-magnification 
view of the junction of the extracellular space (es) with the capillary 
basement membrane (cvbm) at the level of the astrocyte membrane. 
Endothelial cell of the capillary (en); astrocyte of the glia limitans 
(a). Scale bars a 500 nm; b 250 nm
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Gold nanoparticles were distributed through the extracel-
lular spaces of the hippocampal parenchyma and some 
were taken up by neuronal and possibly by astrocyte pro-
cesses (Fig. 4a). However, no nanoparticles were identified 
within capillary basement membranes (Fig. 4b) although 
they were in the pericapillary extracellular spaces and 
within adjacent neuronal processes. These results suggest 
that although 15 nm nanoparticles are widely distributed 
through the extracellular spaces they do not enter base-
ment membranes of the perivascular lymphatic drainage 
pathway.
Distribution in the brain of 15 nm nanoparticles 
injected into the CSF
We have shown that soluble biotinylated Aβ injected into 
the extracellular spaces of the hippocampus readily enters 
basement membranes around capillaries that form the ini-
tial part of the lymphatic drainage pathway of the brain. 
15 nm nanoparticles, on the other hand, do not enter capil-
lary basement membranes from the extracellular spaces of 
the brain parenchyma. We therefore tested the capacity of 
the entry route for CSF into the brain by injecting 15 nm 
nanoparticles into the CSF. Here we show that 15 nm nano-
particles do enter the brain from the CSF but that the route 
of entry is along basement membranes on the outer aspect 
of arteries as they enter the cerebral cortex. No nanopar-
ticles were observed around veins and no nanoparticles 
entered the extracellular spaces of the brain parenchyma 
around arteries.
Figure 5 shows an artery near the surface of the mouse 
cerebral cortex with a compact wall and no perivascu-
lar space. An area of wall in the square box in Fig. 5a is 
shown at higher magnification in Fig. 5b. A group of 
15 nm gold nanoparticles with some single nanoparti-
cles is present mainly in the basement membrane on the 
outer aspect of the artery between the layer of leptomenin-
geal pia mater and the astrocyte layer of glia limitans of 
Fig. 2  Biotinylated Aβ identified in the extracellular space of hip-
pocampal grey matter and in a capillary basement membrane. a 
Hippocampal neuropil showing darkly stained biotinylated Aβ in 
the extracellular spaces (arrows labelled Aβ); b capillary in the hip-
pocampus showing darkly stained biotinylated Aβ in the basement 
membrane; c high-magnification view of the area within the square 
in Fig. 2b showing darkly stained biotinylated Aβ in the extracellular 
space (right) and throughout the capillary basement membrane (left) 
that encapsulates a pericyte (p); d capillary from a control hippocam-
pus, into which no biotinylated Aβ has been injected. The basement 
membrane (cvbm) is negative for Aβ staining. en endothelium, lu 
lumen, p pericyte, cvbm cerebrovascular basement membrane. Scale 
bars a 500 nm; b–d 200 nm
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the brain (Fig. 5b). This layer of basement membrane is 
shared by pia mater and glia limitans (the pial-glial base-
ment membrane) and is distinct from the layers of base-
ment membrane surrounding smooth muscle cells in the 
tunica media that act as the pathway for drainage of fluid 
and solutes out of the brain. Figure 5a, b also shows that 
there is no space between layers of the artery wall and the 
glia limitans.
Fig. 3  Immunocytochemistry/confocal images showing that 5 min 
after the injection of soluble Aβ into the hippocampus, Aβ is associ-
ated with basement membrane proteins within the wall of an artery in 
the hippocampal fissure. a Aβ (red) in the wall of a leptomeningeal 
artery; b laminin (blue); c a layer of smooth muscle cells (green) in 
the artery wall that is most clearly seen when the vessel is cut in cross 
section; d a merged image showing co-localisation of Aβ and laminin 
(purple–see arrows) associated with the smooth muscle cells. The 
outermost layer of the artery, the tunica adventitia (ta), is stained only 
for laminin (blue) and not for Aβ. SP5 Leica confocal image. Scale 
bar 50 μm
Fig. 4  Nanoparticles are distributed in the extracellular spaces but 
do not enter the capillary basement membrane. a Densely stained 
punctate nanoparticles are seen in the extracellular spaces (es) of the 
brain and within cell processes of neurons and possibly of astrocytes. 
b Neuropil and capillary showing nanoparticles (np) in the extracel-
lular spaces of the neuropil and occasionally in cell processes but no 
nanoparticles are located in the capillary basement membrane (cvbm). 
Scale bars a 300 nm; b 500 nm
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Discussion
The major purpose of the present study was to gather fur-
ther evidence for the hypothesis that vascular basement 
membranes form the pathways for passage of fluid into and 
out of the brain. We first showed that when biotinylated Aβ 
is injected in small volumes into the hippocampal grey mat-
ter, it spreads through the extracellular spaces and enters 
basement membranes of capillaries within 5 min of injec-
tion. Electron microscope images show continuity between 
the extracellular spaces and capillary basement membranes. 
Using fluorescent Aβ, we showed by confocal microscopy 
that it was also present in the basement membrane associ-
ated with smooth muscle cells in leptomeningeal arteries 
within 5 min. When injected into the hippocampus, 15 nm 
gold nanoparticles spread through the extracellular spaces 
but they did not enter the basement membranes of capillar-
ies. This suggests that there is a limit on size, rigidity and 
perhaps on charge of material that will enter capillary base-
ment membranes to drain out of the brain along the intra-
mural perivascular drainage pathway.
Our second series of experiments showed that when 
15 nm gold nanoparticles were injected into the CSF in the 
cisterna magna, they rapidly entered the brain alongside 
artery walls. Within 5 min, nanoparticles were present in 
the pial-glial basement membranes on the outer aspects of 
arteries penetrating the cerebral cortex but did not enter 
the extracellular spaces of the brain parenchyma. The pial-
glial basement membrane pathway for the entry of tracers 
from the CSF into the brain is separate from the pathway 
for intramural perivascular drainage of fluid and solutes out 
of the brain that is situated within the smooth muscle cell 
basement membranes in the tunica media of arteries [7]. 
The drainage of solutes along the basement membranes of 
capillaries and arteries is towards the large leptomeningeal 
arteries most likely to the deep cervical lymphatics. From 
the striatum, solutes may appear to drain also into the ven-
tricles, probably an underlying mechanism for the elimi-
nation of periventricular oedema that is observed in some 
neurological conditions or after head trauma [4].
The findings in this study have been combined with pre-
vious observations and summarised in Figs. 6 and 7. ISF 
and soluble tracers flow out of the brain along basement 
membranes initially in the walls of capillaries and then 
along basement membranes surrounding smooth muscle 
cells in the tunica media of arteries (shown as a continuous 
red line in Fig. 6). Tracers from the CSF, on the other hand, 
enter the brain along basement membranes on the outside 
of arteries between the pia mater covering of the artery and 
the glia limitans (Fig. 6). Previous studies have shown that 
when particulate tracers such as Indian ink are injected into 
the cisterna magna they pass into basal cisterns of the sub-
arachnoid space and spread along narrow channels either 
side of major cerebral arteries over the lateral surfaces of 
the hemisphere [17]. From this compartment of the suba-
rachnoid space, nanoparticles appear to pass through the 
pia mater on the surface of the brain to enter the pial-glial 
basement membranes on the outer aspects of penetrating 
arteries as shown in Fig. 6. A recent study demonstrated 
that soluble tracers penetrated the parenchyma after injec-
tion into cisterna magna, with 3 kDa tracers reaching 
64 μm cortical depth [4]. The permeability characteristics 
of the mouse pia mater have not been fully defined and 
require further investigation in future studies.
Fig. 5  Distribution in the brain of 15 nm nanoparticles injected into 
the CSF. Groups of 15 nm nanoparticles are present in the pial-glial 
basement membrane of a cortical artery 5 min after injection into the 
CSF of the cisterna magna. a Low-power transmission electronmicro-
graph of an artery near the surface of the cerebral cortex. Note that 
cells and basement membranes form compact layers and there is no 
Virchow–Robin space. Dense nanoparticles form lines or groups in 
the pial-glial basement membrane between the pia mater and the glia 
limitans around nearly half the circumference of the artery but no 
nanoparticles are seen in basement membranes between smooth mus-
cle cells. b Higher magnification of the square labelled 1 in a. Layers 
of the artery wall can be identified moving outwards from the lumen 
(lu) through the endothelium (en), smooth muscle coat (sm) and a 
layer of pia mater (pm) to the glia limitans of the brain parenchyma 
(pa). Dense groups and single nanoparticles (np) are located mainly 
in the pial-glial basement membrane (cvbm) between the pia mater 
(pm) and the adjacent glia limitans. Scale bars a 1 μm; b 500 nm
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The separation between entry and exit routes is empha-
sised in Fig. 7a. The entry route is depicted by a green 
arrow with two asterisks in the pial-glial basement mem-
brane, whereas the route for the lymphatic outflow of ISF 
and tracers is shown by the red arrow with one asterisk 
associated with smooth muscle cells in the tunica media. 
Uptake of tracer by smooth muscle cells in the artery 
wall suggests that solutes passing out of the brain by this 
pathway may have a signalling function for vascular 
activity. Similarly, the uptake of tracers by perivascular 
macrophages may serve an immunological function or act 
as a mechanism for elimination of metabolites as they pass 
along the lymphatic drainage pathways [12].
Figure 7b is a detailed view of a capillary wall and the 
surrounding glia limitans. Results of the present study sug-
gest that soluble tracers injected into the parenchyma of the 
hippocampus enter capillary basement membranes and then 
flow out of the brain along arterial basement membranes. 
Rennels showed in 1985 that when the soluble tracer horse-
radish peroxidase is injected into the CSF it penetrates the 
brain along the outer aspects of artery walls and reaches 
capillary basement membranes [20]. Aquaporin 4 is 
involved in the transfer of tracers from perivascular base-
ment membranes into the ISF of the brain parenchyma [15] 
but the mechanisms of transfer of ISF and solutes from the 
brain parenchyma into capillary basement membranes are 
unclear. There also appears to be traffic of nutrients through 
capillary basement membranes as they pass into the brain 
via the blood–brain barrier [1] making the system even 
more complex (Fig. 7b).
Basement membranes as routes for transport of fluid 
and solutes in and out of the brain
The present study demonstrates that the anatomical com-
partments for bulk flow of fluid into and out of the brain 
are along basement membranes. All the vascular basement 
membranes involved in this process appear to be com-
posed of two elements. Capillary basement membranes 
are formed by the fusion of elements from endothelium 
and from glia limitans. Basement membranes in the tunica 
media are formed by fusion of elements from adjacent 
smooth muscle cells. The pial-glial basement membrane 
that acts as a pathway for the entry of tracers from the CSF 
is partly contributed by the pia mater and partly by the glia 
limitans. Ultrastructural studies have identified three layers 
in such basement membranes, two outer laminae rarae and 
a central lamina densa at the site where the two elements 
of the basement membrane fuse. Although in the present 
study, Aβ filled the whole width of the capillary basement 
membrane, there is some indication that the lamina densa 
may be the route for transport of solutes along basement 
membranes between vascular smooth muscle cells. Fibrils 
of insoluble Aβ first precipitate in the lamina densa in the 
very early stages of cerebral amyloid angiopathy (CAA) 
[26]. Subsequently deposits of Aβ expand and separate the 
two elements of adjacent smooth muscle basement mem-
brane [16]. Similar separation of the two elements of the 
glio-pial basement membrane occurs when particles are 
injected into the brain and spread between walls of arteries 
and the surrounding glia limitans [29].
Fig. 6  Schematic representation of the lymphatic drainage and con-
vective influx/glymphatic systems of the brain. An artery enters the 
brain from the subarachnoid space and an arteriole divides into cap-
illaries. At the top of the figure, the artery is lined by endothelium 
(Endo), and coated by the tunica media (TM) composed of smooth 
muscle cells and by the outermost tunica adventitia (TA) composed 
of connective tissue. As it enters the brain, the artery loses the 
tunica adventitia but is still coated by a layer of pia-arachnoid (Pia) 
that intervenes between the artery and the glia limitans (GL) of the 
brain. As the arteriole divides into capillaries, the tunica media and 
the layer of pia mater are lost. Thus, at the level of the capillary, the 
glia limitans is in direct contact with the wall of the capillary. On the 
right-hand side of the diagram, the red arrows indicate the intramural 
perivascular lymphatic drainage pathway by which interstitial fluid 
(ISF) and solutes pass out of the brain along basement membranes 
in the walls of capillaries and along basement membranes surround-
ing smooth muscle cells in the tunica media of arterioles and arteries 
[7]. Tracers in the CSF enter the brain along the pial-glial basement 
membrane between the pia mater and the glia limitans (indicated by a 
green arrow) and enter the brain parenchyma and interstitial fluid by 
an aquaporin 4-dependent mechanism, which is the convective influx/
glymphatic pathway
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Significance for neuroimmunology, Alzheimer’s disease, 
drug delivery and the concept of the Virchow–Robin 
space
Neuroimmunology
Drainage of solutes but not nanoparticles from the extracel-
lular spaces of the brain into capillary basement membranes 
is the start of the rapid and direct lymphatic drainage path-
way to cervical lymph nodes. This pathway continues from 
capillaries along basement membranes in the tunica media 
of cerebral and leptomeningeal arteries; it allows passage 
of solutes at least up to 150 kDa [3] but not the passage of 
15 nm nanoparticles as shown in the present study. Immune 
complexes consisting of antigen, antibody and compliment 
becoming entrapped in the basement membrane drainage 
pathway in arteries and temporarily impair perivascular 
lymphatic drainage [9]. These observations suggest that 
there is a size limit on material passing directly from the 
brain parenchyma to lymph nodes. It is likely that the base-
ment membrane pathways are not large enough to allow 
passage of antigen presenting cells or lymphocytes directly 
from the brain to lymph nodes. This has direct implications 
for neuroimmunology and the failure of direct transport of 
antigen presenting cells and lymphocytes from the brain to 
regional lymph nodes may play a role in immunological 
privilege in the brain [19].
Alzheimer’s disease
Perivascular lymphatic drainage pathways are routes for 
the elimination of Aβ from the brain parenchyma as shown 
by injection studies in the mouse. As elimination of Aβ 
fails with ageing of cerebral blood vessels, Aβ accumu-
lates in the walls of arteries as cerebral amyloid angiopa-
thy [16]. Age-related failure of elimination of Aβ probably 
reflects failure of elimination of other metabolites and is 
associated with a rise in the level of soluble Aβ in the brain 
that in itself reflects failure of homoeostasis of the extra-
cellular environment [25]. Failure of elimination of Aβ 
along capillary and arterial basement membranes with age 
could be the trigger for the amyloid cascade that drives the 
deposition of insoluble Aβ in plaques in the brain and fur-
thermore may promote the propagation of tau pathology 
Fig. 7  Expanded view of the wall of a cerebral artery near the sur-
face of the cerebral cortex. a The lymphatic drainage pathway for 
interstitial fluid (ISF) and solutes is specifically along basement 
membranes surrounding smooth muscle cells in the tunica media 
(red arrow *). Tracer studies have shown that solutes are taken up 
by smooth muscle cells and by perivascular macrophages (PVM) 
(thin red arrows). The convective influx/glymphatic pathway by 
which CSF enters the brain is along the pial-glial basement mem-
brane (BM4–green arrow **) between the layer of pia mater and the 
glia limitans of the brain parenchyma. Abbreviations for structure of 
the artery wall: Endo endothelium, BM basement membrane, SMC 
smooth muscle cells, GL glia limitans, BM1 basement membrane 
formed by the endothelium and adjacent smooth muscle cells, BM2 
basement membrane formed by adjacent smooth muscle cells; this is 
the pathway for the lymphatic drainage of interstitial fluid and sol-
utes from the brain along the tunica media, BM3 basement membrane 
formed by the outer smooth muscle cells and pia mater cells coating 
the artery, BM4 basement membrane formed by the pia mater and 
astrocytes of the glia limitans. It is along BM4 that CSF and nano-
particles enter the brain in the convective influx/glymphatic system. 
b Expanded view of the wall of a cerebral capillary and surround-
ing glia limitans. The endothelium has a basement membrane that 
is formed partly by endothelial cells and partly by astrocytes of the 
glia limitans. Solutes, such as amyloid β (Aβ) in the interstitial fluid 
pass from the extracellular spaces of the brain into the endothelial-
glial basement membrane and drain along the intramural perivascular 
drainage pathway (red arrow). Tracers injected into the CSF reach the 
capillary basement membranes via the convective influx/glymphatic 
system and their entry into the interstitial fluid is dependent upon 
aquaporin 4 (green arrows). Nutrients from the blood through the 
blood–brain barrier pass into the brain through the endothelium, the 
basement membrane and the glia limitans (purple arrow). Pericytes 
are surrounded by basement membrane and lie between the endothe-
lium (Endo) and the basement membrane (BM) of the glia limitans 
(GL). Although the red and green arrows are shown in separate parts 
of the basement membrane, a single capillary basement membrane 
appears to share traffic of fluid into and out of the brain
▸
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and neuro fibrillary tangles in the brain in Alzheimer’s dis-
ease [25].
Drug delivery
Convection-enhanced delivery (CED) is a strategy for 
injecting drugs into the brain parenchyma to bypass 
the bloodbrain barrier. This technique has shown sig-
nificant potential in clinical trials for the treatment of 
malignant gliomas and Parkinson’s disease [6, 10]. The 
present study emphasises the anatomical basis for this 
technique. Solutes up to 150 kDa drain rapidly out of 
the brain along basement membranes of cerebral capil-
laries and cerebral arteries following simple injection or 
CED [3, 7]. Solutes of 70 and 150 kDa show some delay 
drainage [3]. Particulate matters such as 15–20 nm nan-
oparticles, 0.2 μm fluorospheres and Indian ink do not 
enter the basement membranes of the lymphatic drain-
age pathway but they do track along the pial-glial base-
ment membrane and separate the glia limitans from the 
surface of arteries [7, 29]. Indian ink injected into the 
rat brain remains in situ around arteries for up to 2 years 
having been ingested by perivascular macrophages [29]. 
Uptake of particles at this site by perivascular mac-
rophages is not as rapid as the uptake of solutes drain-
ing along the intramural perivascular pathways within 
the tunica media of arteries [3]. The compartment that 
is expanded by the injection of particulate matter into 
the brain parenchyma is the same pial-glial compartment 
along which nanoparticles enter the brain from the CSF 
as shown in the present study.
The concept of the Virchow–Robin space
The term “Virchow–Robin space” is widely used to denote 
dilated perivascular spaces particularly in the basal gan-
glia and white matter of the brain. It has also long been 
assumed that there is a physically empty space between 
the walls of arteries penetrating the cerebral cortex and 
the surrounding brain tissue [5]. However, ultrastructural 
studies by scanning and transmission electron microscopy 
have demonstrated that first a layer of pia mater separates 
the subarachnoid space from the subpial space and perivas-
cular compartments [14] and secondly, there is a compact 
series of layers of cell processes and basement membrane 
between the walls of arteries and the surrounding brain 
tissue and no space as shown in the mouse in the present 
study (Figs. 5, 6) and in the human brain [28]. There is no 
empty “Virchow–Robin space” between the artery wall 
and the glia limitans. Apparent spaces are commonly seen 
in paraffin sections of brain tissue but the space appears 
to be within brain tissue and artefactual as often there are 
astrocyte processes crossing the space [21]. Injection of 
particulate matter into the brain does separate elements of 
the pial-glial basement membrane to form a perivascular 
space [7, 29].
Conclusions
This study has determined the role of cerebral vascular 
basement membranes as pathways for the passage of fluid 
and tracers into and out of the brain. Soluble tracers such 
as Aβ enter capillary basement membranes from the extra-
cellular spaces and drain out of the brain along the base-
ment membranes of cerebral capillaries and arteries as 
part of the rapid and direct lymphatic drainage of the brain 
parenchyma. This pathway does not allow drainage of nan-
oparticles or of antigen presenting cells to regional lymph 
nodes; it also fails as arteries age and is further blocked by 
the deposition of amyloid in cerebral amyloid angiopathy. 
Lymphatic drainage pathways play a significant role in 
neuroimmunology and are an important factor in maintain-
ing immunological privilege. Failure of elimination of Aβ 
along perivascular drainage pathways is a significant factor 
in the development of Alzheimer’s disease. A different peri-
arterial pathway allows CSF and nanoparticles to penetrate 
the brain from the CSF as part of the convective influx/
glymphatic system; this pathway is the pial-glial base-
ment membrane that can be expanded by particulate matter. 
Questions still remain regarding the dynamics and physiol-
ogy of basement membrane pathways for transport of fluid 
into and out of the brain, not least is the question of how 
the capillary basement membrane appears to allow passage 
of fluid and tracers in more than one direction within the 
same structure.
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